Daten des Robert Koch-Instituts: 7-Tage-Inzidenz & Hospitalisierungen & GrippeWeb-Wochenbericht & AMELAG
Das aktuelle Corona-Krankheitsaufkommen in Deutschland beträgt schätzungsweise 490 Fälle pro 100.000 Einwohner, was bedeutet, dass ca. eine von 143 Personen derzeit akut infiziert ist (angenommen sind Ø 10 Tage Infektionsdauer). Das Robert-Koch-Institut (RKI) meldet eine auf meldepflichtigen PCR-Tests basierte Inzidenz von 2, wobei auf jede offiziell registrierte Infektion etwa 248 weitere unentdeckte Fälle entfallen. Informationen zur aktuellen Verteilung zirkulierender SARS-CoV-2-Varianten finden sich im RKI-Dashboard.
Die auf dem GrippeWeb-Wochenbericht basierte Inzidenz aller Atemwegserkrankungen beträgt 5.659 pro 100.000 Einwohner, was bedeutet, dass ca. eine von 18 Personen derzeit akut infiziert ist (angenommen sind Ø 7 Tage Infektionsdauer; Vergleich zu den Vorjahren). Stand: 08.11.2026
Der Risikorechner macht infektiöse Aerosol-Gefahren in Innenräumen sichtbar und unterstützt dabei, das tatsächliche Ansteckungsrisiko realistisch einzuschätzen.
Risiko berechnen
Rund um das Immunsystem gibt es viele Mythen und Missverständnisse. Dieser Text klärt einige häufige Fragen wissenschaftlich fundiert auf.
Weiterlesen
Design and Validation of Multiplexed Respiratory RT-LAMP assay for the differentiation of SARS-CoV-2, Influenza A and Respiratory Syncytial Virus (RSV) in COVID-19 Pandemic Samples from Western Kenya. 08.11.2026
Clinical, laboratory and instrumental features of cardiovascular disorders in children after SARS-CoV-2 infection:pre-war and wartime periods in Ukraine 08.11.2026
REPERCUSSÕES DAS MEDIDAS DE ENFRENTAMENTO À COVID-19 (SARS-COV-2) NO DESENVOLVIMENTO PSICOSSOCIAL E NA ALFABETIZAÇÃO DE ESTUDANTES:UMA REVISÃO INTEGRATIVA 08.11.2026
Long COVID:A Modified Delphi Consensus on Definition, Burden, Diagnosis and Management in Southeast Asia. 07.11.2026
Autopsy findings after SARS-CoV-2 vaccination:a German national registry study. 07.11.2026
Utilization of the Nortropinone Scaffold in the Structure-Guided Design of Potent Inhibitors of Human Cathepsin L and the Chymotrypsin-like Proteases of SARS-CoV-2 and MERS-CoV 07.11.2026
Real-Time Surveillance of SARS-COV-2 Infection in the South-East Health Region in Gabon, Central Africa 07.11.2026
Association between prior HBV vaccine responsiveness and booster-induced anti-SARS-CoV-2 spike antibody titers following the third BNT162b2 dose in Japanese healthcare workers:A prospective observational study 07.11.2026
Autopsy findings after SARS-CoV-2 vaccination:a German national registry study 07.11.2026
AAV-mediated expression of a SARS-CoV-2 neutralizing antibody in monocyte-derived dendritic cells and human airway epithelial cells 07.11.2026
Structure-Guided Optimization of the A58 DNA Aptamer Targeting the SARS-CoV-2 Nucleocapsid Protein Through Integrated Computational Analysis 07.11.2026
Interhemispheric structural connectivity alterations and hierarchical connectome gradient reorganization following SARS-CoV-2 infection 07.11.2026
mRNA-1273.251 and mRNA-1283.251 vaccines expressing SARS-CoV-2 variant LP.8.1 antigens broadly neutralize JN.1-lineage viruses 07.11.2026
AAV-mediated expression of a SARS-CoV-2 neutralizing antibody in monocyte-derived dendritic cells and human airway epithelial cells. 06.11.2026
[Surgery in transition:Impact of the early COVID-19 pandemic on visceral surgery in Germany]. 06.11.2026
Template-dependent RNA polyadenylation by SARS-CoV-2 RNA-dependent RNA polymerase. 06.11.2026
Interhemispheric structural connectivity alterations and hierarchical connectome gradient reorganization following SARS-CoV-2 infection. 06.11.2026
Comprehensive vaccination guidelines for patients with inborn errors of immunity:A European Society for Immunodeficiencies Consensus. 06.11.2026
Self-amplifying RNA vaccines encoding chimeric and mosaic hemagglutinins confer immunity against phylogenetically diverse influenza A viruses. 06.11.2026
Novel Occupational and Environmental Risk Factors for SARS-CoV-2 Infection Among Coal Miners:Longitudinal Cohort Study. 06.11.2026
A Pilot Surveillance Program to Identify Emerging SARS-CoV-2 Variants in International Travelers Arriving at a Major International Airport:Prospective Cohort Evaluation. 06.11.2026
Temporal dynamics of antigen-specific T cell expansion in primary SARS-CoV-2 infection. 06.11.2026
A single-amino acid difference between rodent and human Andes virus affects viral glycoprotein trafficking. 06.11.2026
Association of unmet discharge needs on readmission or mortality among acute respiratory failure survivors during the COVID-19 pandemic:The Addressing Post-Intensive Care Syndrome (APICS-COVID) multicenter prospective cohort study. 06.11.2026
Evaluation of targets for normalization of viral pathogen concentrations in building dust. 06.11.2026
Predicting key viral mutations from within-host deep sequencing data. 06.11.2026
Real-world safety outcomes of COVID-19 mRNA vaccine:A result from Korea post-marketing surveillance. 06.11.2026
Incidence and risk factors of acute respiratory illness associated with influenza, COVID-19, and respiratory syncytial virus within a birth cohort study. 06.11.2026
The magnitude and durability of immune response to the SARS-CoV-2 vaccination among children. 06.11.2026
White-tailed deer milk promotes rapid SARS-CoV-2 RNA degradation through synergistic ionic and enzymatic mechanisms 06.11.2026
A Pilot Surveillance Program to Identify Emerging SARS-CoV-2 Variants in International Travelers Arriving at a Major International Airport:Prospective Cohort Evaluation 06.11.2026
Novel Occupational and Environmental Risk Factors for SARS-CoV-2 Infection Among Coal Miners:Longitudinal Cohort Study (Preprint) 06.11.2026
Time to sustained control of the effective reproduction number as a failure-time estimand:a county-level analysis of the first SARS-CoV-2 wave in the United States. 06.11.2026
Temporal dynamics of antigen-specific T cell expansion in primary SARS-CoV-2 infection 06.11.2026
Structural dynamics and energetic basis of conserved ACE2 binding across SARS-CoV-2 variants 06.11.2026
Template-dependent RNA polyadenylation by SARS-CoV-2 RNA-dependent RNA polymerase 06.11.2026
Sex, age and HIV-1 status influence complement activation against SARS-CoV-2 mRNA vaccine Spike protein 06.11.2026
Isolated superficial venous thrombosis in elderly patients with asymptomatic SARS-CoV-2 infection during the early pandemic confinement 06.11.2026
The magnitude and durability of immune response to the SARS-CoV-2 vaccination among children 06.11.2026
Nasopharyngeal Microbiome Profiles of SARS-CoV-2 RT-PCR Positive and Negative Outpatients in Guayaquil, Ecuador 06.11.2026
Skeletal Muscle Cell Necrosis in Individuals with SARS-CoV-2 Infection:An Autopsy Study 06.11.2026
SARS-CoV-2 Period Seroprevalence Study on Cancer Healthcare Workers in a Rural Cancer Care Network 06.11.2026
Duration and determinants of SARS-CoV-2 RNA positivity in hospitalized patients in Guinea:a prospective cohort study 06.11.2026
A web-based predictor for SARS-CoV-2 neutralizing antibody escape from genome sequences 06.11.2026
In silico Evaluation of ssDNA Aptamer against 2GHV of SARS-CoV 06.11.2026
Humoral immunity after mRNA SARS-CoV-2 XFG vaccination 06.11.2026
State Capture and Institutional Recovery at SARS:Implications for Financial Crime Enforcement in South Africa 06.11.2026
Small molecules targeting SARS-CoV-2 nucleocapsid reveal a conserved RNA-binding vulnerability across human coronaviruses. 05.11.2026
Risk Factors for Incident Diabetes After SARS-CoV-2 Infection Across Variant Eras:Findings From the National Clinical Cohort Collaborative (N3C) COVID-19 Enclave 05.11.2026
<b>Risk Factors for Incident Diabetes following SARS-CoV-2 Infection Across Variant Eras:Findings from the National Clinical Cohort Collaborative (N3C) COVID-19 Enclave</b> 05.11.2026
Expressão do domínio RBD de SARS-CoV-2 em células de mamífero utilizando o sistema >em<Semliki Forest Virus>/em< - SFV. 05.11.2026
Estudo de novas plataformas para vacinas contra SARS-CoV-2 em modelo experimental:avaliação da resposta imune humoral e celular em camundongos adultos 05.11.2026
SARS-CoV-2 Nsp2 reprograms host immunity to drive pathogenic inflammation 05.11.2026
Robust T and B cell activation is associated with rapid clearance of infectious SARS-CoV-2 05.11.2026
COVID‑19 nucleic acid vaccines, their many virtues, some deficiencies and unsuspected novel features. A reflection after pandemic resolution and present endemic SARS-CoV-2 circulation 05.11.2026
Neutralising Antibodies Response Against SARS-CoV-2 Among People Living With HIV in Dar- es-Salaam Tanzania 05.11.2026
Evaluation and Estimation of Epidemic Trajectories for SARS-CoV-2 from Clinical and Wastewater Data in Gauteng Province, South Africa 05.11.2026
Genomic diversity of severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) sequences across six pandemic waves in Pakistan 05.11.2026
Generation of a fully infectious SARS-CoV-2 encoding an internally tagged nsp3. 02.11.2026
Is SARS-CoV-2 Infection (COVID-19) Associated With Congenital Anomalies? A Population Study of Congenital Anomaly Surveillance Data and Maternal SARS-CoV-2 Infection in Wales. 01.11.2026
Deconvolving SARS-CoV-2 mRNA Vaccine Impact on Immunotherapy-Related Survival. 01.11.2026
Global burden of type 2 diabetes attributable to SARS-CoV-2 infection 31.10.2026
Effects of leritrelvir for adults with mild-to-moderate coronavirus disease 2019:a multicenter real-world study. 27.10.2026
Simultaneous detection of influenza and SARS-CoV-2 on an AI-nanopore multiplex platform. 27.10.2026
SARS-CoV-2 ORF6 protein targets IFP35 to inhibit the IFNγ signaling pathway. 26.10.2026
Polymorphism of amyloid fibrils of a SARS-CoV-2 peptide associated with hemagglutination. 26.10.2026
Evaluation of whole genome sequencing protocols and target-capture panels for detection of respiratory viruses in clinical specimens. 23.10.2026
Age-dependent differences in SARS-CoV-2 entry-factor expression and innate immune responses between pediatric and adult liver organoids. 23.10.2026
Integrated mechanistic and serological analyses reveal determinants of antibody-dependent enhancement in respiratory coronaviruses. 23.10.2026
MULTIVALENT ACE2 ENGAGEMENT ACTIVATES PIEZO1-SPHINGOMYELINASE SIGNALING IN SARS-COV-2 SPIKE-MEDIATED CELL-CELL FUSION. 23.10.2026
Persistently activated virus-specific CD8 T cells indicate antigen-driven immune aberrations in long COVID. 22.10.2026
Correction:Insertion outside the supersite in the N-terminal domain of the SARS-CoV-2 spike glycoprotein may contribute to evasion of neutralizing antibodies. 22.10.2026
A novel model demonstrating that human immune cells promote multiorgan SARS-CoV-2 dissemination and human T cells limit anti-viral innate immunity. 22.10.2026
The pan-African natural products library compounds oleanolic acid, poinsettifolin B, and rhuschalcone III disrupt SARS-CoV-2 spike-host ACE2 interactions and SARS-CoV-2 replication. 21.10.2026
Fitting and Selection of Within-Host Models for SARS-CoV-2 Infection 20.10.2026
Deep untargeted wastewater metagenomic sequencing from sewersheds across the United States. 19.10.2026
Interactions between respiratory viruses in US adults and children:a prospective cohort study. 19.10.2026
The Water-Soluble [60]Fullerene Derivatives as Binders of SARS-CoV‑2 Proteins 16.10.2026
Evolution of SARS-CoV-2 reshapes upper airway immunity in children 16.10.2026
Global burden of type 2 diabetes attributable to SARS-CoV-2 infection. 16.10.2026
Iron Status in Patients with SARS-CoV-2 Infection. 15.10.2026
Scaling of SARS-CoV-2 Genomic Divergence with Cumulative COVID-19 Infections. 15.10.2026
11 million days of longitudinal Fitbit data reveal novel future health insights. 14.10.2026
SARS-CoV-2 nucleocapsid protein hijacks host transcription by targeting eEF1A1. 14.10.2026
SARS-CoV-2 seeds IAPP aggregation and β-cell failure. 09.10.2026
Transcriptional responses of white-tailed deer to SARS-CoV-2 challenge 07.10.2026
Social inequalities in SARS-CoV-2 infection in France:An intersectional analysis 01.10.2026
Influenza A (H1N1) and SARS-CoV-2 Transmission in Airplanes:Quanta Profiles and Infection Control. 01.10.2026
Divergent systemic and airway mucosal adaptive immunity to SARS-CoV-2 in African adults 29.09.2026
The other immune landscape of SARS-CoV-2 evolution. 28.09.2026
Localized SARS-CoV-2 Infection Triggers a Tissue-Wide Antiviral Response and Functional Impairment of Olfactory Sensory Neurons. 21.09.2026
Epistasis and the changing fitness landscapes of SARS-CoV-2. 17.09.2026
Role of Ion Channels in the Pathophysiology of SARS-CoV-2. 16.09.2026
Healthy vaccinee effect in SARS-CoV-2 vaccinees without documented infection 11.09.2026
Gut microbial allies and adversaries in SARS-CoV-2 infection. 10.09.2026
Epitope-driven polyfunctional divergence of SARS-CoV-2 RBD antibodies 07.09.2026
A Selenium-Deficient Mouse Model of Mouse-Adapted SARS-CoV-2 Demonstrates Variant Emergence Observed in SARS-CoV-2 Pandemic Variants 26.08.2026
Antibody-mediated SARS-CoV-2 entry and conformational regulation. 21.08.2026
The effects of SARS-CoV-2 on bone homeostasis. 03.08.2026
Quellen: PubMed, Europe PMC & CrossRef
GSK und Moderna legen Impfstoff-Streit bei - Börsen-Zeitung 08.11.2026
Grippeimpfung: Für wen sie besonders wichtig ist - SZ.de 08.11.2026
Hamburg impft ohne Termin – auch nach Feierabend - MOPO 07.11.2026
Chronische Erschöpfung: Wie Covid die vernachlässigte Forschung belebte - aktien.news 07.11.2026
Pandemie hinterließ biologische Spuren bei Jugendlichen - WEB.DE 06.11.2026
Folgen der Coronapandemie Mehr als 1100 Menschen klagen offenbar wegen Impfschäden - Tagesspiegel 06.11.2026
Kostenlose Grippe- und COVID-19-Impfungen - Stadt Salzburg 06.11.2026
Marburger Experten erklären, welche Rolle Ernährung bei Post-Covid spielt - Mittelhessen 06.11.2026
Jugendliche mit Covid-bedingtem Stress altern epigenetisch schneller - Max-Planck-Gesellschaft 06.11.2026
Baillie-Gifford-Partnerin: „Biontech fehlt es an Fokus" - FAZ 06.11.2026
Covid-19-Stress beschleunigt bei Jugendlichen das epigenetische Altern - Scinexx 05.11.2026
Kann Kortison bei Post-Covid die Beschwerden lindern? - STERN.de 05.11.2026
Impfangebot der Apotheken wird zunehmend bekannter - Ärzte Zeitung 05.11.2026
Diese Marler Apotheken impfen gegen Grippe und Covid: Termine und Beratung vor Ort - Marler Zeitung 04.11.2026
Studie zu Post-COVID-Syndrom zeigt Potenzial von Cortison - RTF.1 Regionalfernsehen 02.11.2026
Symposium zu Long COVID - Mittelhessen 02.11.2026
Wie verbreitet ist das Coronavirus aktuell in Bayern? Das zeigen aktuelle Abwasser-Daten - Augsburger Allgemeine 02.11.2026
Homepage | Reha-Angebot für COVID-19-Erkrankte - Deutsche Rentenversicherung 20.05.2026
Homepage | Eckpunktepapier für die medizinische Rehabilitation bei Post-COVID-Syndrom - Deutsche Rentenversicherung 20.05.2026
Rückblick auf die durch Long COVID verlorenen Jahre: Susans Geschichte - World Health Organization (WHO) 16.03.2026
Quelle: Google News
Für Regen gibt es Radar, für Viren jetzt eine Ampel. Die neue Virenampel zeigt auf einen Blick, welche Atemwegserkrankungen gerade verbreitet sind.
Pluslife ist ein Molekulartest (PoC-NAT) für zuhause: besser als Antigen-Schnelltests bei niedriger Viruslast – und mit Analyzer-Webapp von »virus.sucks« werden Ergebnisse nachvollziehbar.
Safe Air Docs hilft dabei, Arztpraxen mit hohen Infektionsschutzstandards zu finden. So wird der Arztbesuch sicherer – besonders für Menschen mit erhöhtem Gesundheitsrisiko.
Am 15. und 16. Mai 2024 fand die virtuelle Konferenz #UniteToFight2024 statt und zog über 10.000 Teilnehmer an, die sich über die neuesten Entwicklungen zu Long Covid und ME/CFS informierten. Führende Experten wie Dr. David Putrino und Prof. Akiko Iwasaki präsentierten aktuelle Forschungsergebnisse.
Die Übertragung durch Aerosole ist einer der am schwierigsten zu vermeidenden Infektionswege, kann aber durch FFP2- und FFP3-Masken effektiv blockiert werden.
2023: Golda Schlaff und 15 weitere prominente Ärzt:innen fordern mehr Respekt vor den Patient:innen, die Wiedereinführung von FFP2-Masken bei steigenden Inzidenzen sowie den flächendeckenden Einsatz von HEPA-Filtern in medizinischen Einrichtungen.